Chinese approval for Vocabria combined with Rekambys, an HIV-1 injectable treatment, is granted to GSK's ViiV Healthcare.

Published Date: 27 Oct 2023

London: ViiV Healthcare, a worldwide HIV specialty company that is primarily owned by GSK and has Pfizer and Shionogi as shareholders, was launched.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC

2.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

3.

Surviving cancer, still suffering: Survey reveals gaps in follow‑up care

4.

Charles III, King of Kings, is Cancerous.

5.

The Truth About Apple AirPods


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot